Suggested Dosing
Medicinal mushroom extract (liquid, tablet, capsule) 3-7.0 g/d PO
Maitake mushrooms: may be consumed as food or made into tea
Suggested Uses
Treatment or prevention of cancer
Boosts human immune system & limits or reverses tumor growth
Enhances benefits of chemo & lessens side effects of hair loss, pain, & nausea
Clinical trials currently undergoing study:
to learn if beta glucan can increase effectiveness of rituximab by making cancer cells more sensitive to it
of young patients with relapsed or progressive lymphoma, leukemia, or similar d/o
with other drugs to learn if they increase effectiveness of another monoclonal antibody
for breast cancer treatment; neuroblastoma patients that have not responded to treatment
combining different types of biological treatment
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (46)
- adalimumab
adalimumab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- alefacept
alefacept increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- anakinra
anakinra increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- antithymocyte globulin equine
antithymocyte globulin equine increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- antithymocyte globulin rabbit
antithymocyte globulin rabbit increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- azathioprine
azathioprine increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- basiliximab
basiliximab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- bendroflumethiazide
maitake increases effects of bendroflumethiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- bumetanide
maitake increases effects of bumetanide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- canakinumab
canakinumab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- candesartan
maitake increases effects of candesartan by pharmacodynamic synergism. Use Caution/Monitor.
- chlorothiazide
maitake increases effects of chlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- chlorthalidone
maitake increases effects of chlorthalidone by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- cyclopenthiazide
maitake increases effects of cyclopenthiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- eprosartan
maitake increases effects of eprosartan by pharmacodynamic synergism. Use Caution/Monitor.
- etanercept
etanercept increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- ethacrynic acid
maitake increases effects of ethacrynic acid by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- everolimus
everolimus increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- furosemide
maitake increases effects of furosemide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- glatiramer
glatiramer increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- golimumab
golimumab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- hydrochlorothiazide
maitake increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- hydroxychloroquine sulfate
hydroxychloroquine sulfate increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- indapamide
maitake increases effects of indapamide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- infliximab
infliximab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- irbesartan
maitake increases effects of irbesartan by pharmacodynamic synergism. Use Caution/Monitor.
- leflunomide
leflunomide increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- losartan
maitake increases effects of losartan by pharmacodynamic synergism. Use Caution/Monitor.
- mercaptopurine
mercaptopurine increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- methotrexate
methotrexate increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- methyclothiazide
maitake increases effects of methyclothiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- metolazone
maitake increases effects of metolazone by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- muromonab CD3
muromonab CD3 increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- mycophenolate
mycophenolate increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- olmesartan
maitake increases effects of olmesartan by pharmacodynamic synergism. Use Caution/Monitor.
- rilonacept
rilonacept increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- sacubitril/valsartan
maitake increases effects of sacubitril/valsartan by pharmacodynamic synergism. Use Caution/Monitor.
- sirolimus
sirolimus increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- tacrolimus
tacrolimus increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- telmisartan
maitake increases effects of telmisartan by pharmacodynamic synergism. Use Caution/Monitor.
- temsirolimus
temsirolimus increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- tocilizumab
tocilizumab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor. .
- tongkat ali
tongkat ali increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- torsemide
maitake increases effects of torsemide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).
- ustekinumab
ustekinumab increases and maitake decreases immunosuppressive effects; risk of infection. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- valsartan
maitake increases effects of valsartan by pharmacodynamic synergism. Use Caution/Monitor.
Minor (113)
- acarbose
maitake increases effects of acarbose by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- acebutolol
maitake increases effects of acebutolol by pharmacodynamic synergism. Minor/Significance Unknown.
- amiloride
maitake increases effects of amiloride by pharmacodynamic synergism. Minor/Significance Unknown.
- amlodipine
maitake increases effects of amlodipine by pharmacodynamic synergism. Minor/Significance Unknown.
- astragalus
astragalus and maitake both decrease immunosuppressive effects; risk of infection. Minor/Significance Unknown.
- atenolol
maitake increases effects of atenolol by pharmacodynamic synergism. Minor/Significance Unknown.
- benazepril
maitake increases effects of benazepril by pharmacodynamic synergism. Minor/Significance Unknown. Additive hypotensive effects.
- betaxolol
maitake increases effects of betaxolol by pharmacodynamic synergism. Minor/Significance Unknown.
- bicalutamide
maitake increases effects of bicalutamide by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- bisoprolol
maitake increases effects of bisoprolol by pharmacodynamic synergism. Minor/Significance Unknown.
- bosentan
maitake increases effects of bosentan by pharmacodynamic synergism. Minor/Significance Unknown.
- capecitabine
maitake increases effects of capecitabine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- captopril
maitake increases effects of captopril by pharmacodynamic synergism. Minor/Significance Unknown. Both drugs decrease blood glucose and blood pressure. Monitor blood glucose and blood pressure.
- carvedilol
maitake increases effects of carvedilol by pharmacodynamic synergism. Minor/Significance Unknown.
- celiprolol
maitake increases effects of celiprolol by pharmacodynamic synergism. Minor/Significance Unknown.
- chlorpropamide
maitake increases effects of chlorpropamide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- cladribine
maitake increases effects of cladribine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- clevidipine
maitake increases effects of clevidipine by pharmacodynamic synergism. Minor/Significance Unknown.
- clonidine
maitake increases effects of clonidine by pharmacodynamic synergism. Minor/Significance Unknown.
- cytarabine
maitake increases effects of cytarabine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- decitabine
maitake increases effects of decitabine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- diltiazem
maitake increases effects of diltiazem by pharmacodynamic synergism. Minor/Significance Unknown.
- docetaxel
maitake increases effects of docetaxel by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- drospirenone
maitake increases effects of drospirenone by pharmacodynamic synergism. Minor/Significance Unknown.
- echinacea
echinacea and maitake both decrease immunosuppressive effects; risk of infection. Minor/Significance Unknown.
- enalapril
maitake increases effects of enalapril by pharmacodynamic synergism. Minor/Significance Unknown.
- eplerenone
maitake increases effects of eplerenone by pharmacodynamic synergism. Minor/Significance Unknown.
- epoprostenol
maitake increases effects of epoprostenol by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- esmolol
maitake increases effects of esmolol by pharmacodynamic synergism. Minor/Significance Unknown.
- felodipine
maitake increases effects of felodipine by pharmacodynamic synergism. Minor/Significance Unknown.
- fenoldopam
maitake increases effects of fenoldopam by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- floxuridine
maitake increases effects of floxuridine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- fludarabine
maitake increases effects of fludarabine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- fluorouracil
maitake increases effects of fluorouracil by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- flutamide
maitake increases effects of flutamide by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- fosinopril
maitake increases effects of fosinopril by pharmacodynamic synergism. Minor/Significance Unknown.
- fulvestrant
maitake increases effects of fulvestrant by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- gemcitabine
maitake increases effects of gemcitabine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- glimepiride
maitake increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- glipizide
maitake increases effects of glipizide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- glyburide
maitake increases effects of glyburide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- goserelin
maitake increases effects of goserelin by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- guanfacine
maitake increases effects of guanfacine by pharmacodynamic synergism. Minor/Significance Unknown.
- hydralazine
maitake increases effects of hydralazine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- iloprost
maitake increases effects of iloprost by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- imidapril
maitake increases effects of imidapril by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin aspart
maitake increases effects of insulin aspart by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- insulin detemir
maitake increases effects of insulin detemir by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- insulin glargine
maitake increases effects of insulin glargine by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- insulin glulisine
maitake increases effects of insulin glulisine by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- insulin lispro
maitake increases effects of insulin lispro by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- insulin NPH
maitake increases effects of insulin NPH by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- insulin regular human
maitake increases effects of insulin regular human by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- isradipine
maitake increases effects of isradipine by pharmacodynamic synergism. Minor/Significance Unknown.
- ketanserin
maitake increases effects of ketanserin by pharmacodynamic synergism. Minor/Significance Unknown.
- labetalol
maitake increases effects of labetalol by pharmacodynamic synergism. Minor/Significance Unknown.
- leuprolide
maitake increases effects of leuprolide by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- lisinopril
maitake increases effects of lisinopril by pharmacodynamic synergism. Minor/Significance Unknown.
- mecamylamine
maitake increases effects of mecamylamine by pharmacodynamic synergism. Minor/Significance Unknown.
- medroxyprogesterone
maitake increases effects of medroxyprogesterone by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- megestrol
maitake increases effects of megestrol by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- mercaptopurine
maitake increases effects of mercaptopurine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- metformin
maitake increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- methotrexate
maitake increases effects of methotrexate by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- metoprolol
maitake increases effects of metoprolol by pharmacodynamic synergism. Minor/Significance Unknown.
- metyrosine
maitake increases effects of metyrosine by pharmacodynamic synergism. Minor/Significance Unknown.
- miglitol
maitake increases effects of miglitol by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- minoxidil
maitake increases effects of minoxidil by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- moexipril
maitake increases effects of moexipril by pharmacodynamic synergism. Minor/Significance Unknown.
- moxonidine
maitake increases effects of moxonidine by pharmacodynamic synergism. Minor/Significance Unknown.
- nadolol
maitake increases effects of nadolol by pharmacodynamic synergism. Minor/Significance Unknown.
- nateglinide
maitake increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- nebivolol
maitake increases effects of nebivolol by pharmacodynamic synergism. Minor/Significance Unknown.
- nelarabine
maitake increases effects of nelarabine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- nicardipine
maitake increases effects of nicardipine by pharmacodynamic synergism. Minor/Significance Unknown.
- nifedipine
maitake increases effects of nifedipine by pharmacodynamic synergism. Minor/Significance Unknown.
- nilutamide
maitake increases effects of nilutamide by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- nisoldipine
maitake increases effects of nisoldipine by pharmacodynamic synergism. Minor/Significance Unknown.
- oxaliplatin
maitake increases effects of oxaliplatin by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- paclitaxel
maitake increases effects of paclitaxel by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- paclitaxel protein bound
maitake increases effects of paclitaxel protein bound by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- penbutolol
maitake increases effects of penbutolol by pharmacodynamic synergism. Minor/Significance Unknown.
- pentostatin
maitake increases effects of pentostatin by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- perindopril
maitake increases effects of perindopril by pharmacodynamic synergism. Minor/Significance Unknown.
- pindolol
maitake increases effects of pindolol by pharmacodynamic synergism. Minor/Significance Unknown.
- pioglitazone
maitake increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- pralatrexate
maitake increases effects of pralatrexate by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- propranolol
maitake increases effects of propranolol by pharmacodynamic synergism. Minor/Significance Unknown.
- quinapril
maitake increases effects of quinapril by pharmacodynamic synergism. Minor/Significance Unknown.
- ramipril
maitake increases effects of ramipril by pharmacodynamic synergism. Minor/Significance Unknown.
- repaglinide
maitake increases effects of repaglinide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- rosiglitazone
maitake increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- saxagliptin
maitake increases effects of saxagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- sitagliptin
maitake increases effects of sitagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- sotalol
maitake increases effects of sotalol by pharmacodynamic synergism. Minor/Significance Unknown.
- spironolactone
maitake increases effects of spironolactone by pharmacodynamic synergism. Minor/Significance Unknown.
- tamoxifen
maitake increases effects of tamoxifen by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- thioguanine
maitake increases effects of thioguanine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- timolol
maitake increases effects of timolol by pharmacodynamic synergism. Minor/Significance Unknown.
- tolazamide
maitake increases effects of tolazamide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- tolbutamide
maitake increases effects of tolbutamide by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- toremifene
maitake increases effects of toremifene by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- trandolapril
maitake increases effects of trandolapril by pharmacodynamic synergism. Minor/Significance Unknown.
- treosulfan
maitake increases effects of treosulfan by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- treprostinil
maitake increases effects of treprostinil by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- triamterene
maitake increases effects of triamterene by pharmacodynamic synergism. Minor/Significance Unknown.
- triptorelin
maitake increases effects of triptorelin by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- verapamil
maitake increases effects of verapamil by pharmacodynamic synergism. Minor/Significance Unknown.
- vildagliptin
maitake increases effects of vildagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).
- vinblastine
maitake increases effects of vinblastine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- vincristine
maitake increases effects of vincristine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- vincristine liposomal
maitake increases effects of vincristine liposomal by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
- vinorelbine
maitake increases effects of vinorelbine by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research).
Adverse Effects
None reported
Warnings
Cautions
Commercial preparations may vary in strength, check Mfr's label
Pregnancy & Lactation
Pregnancy Category: check with physician
Lactation: check with physician
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Maitake D-fraction contains a polysaccharide called beta-glucan believed to stimulate & activate certain immune cells & proteins that attack cancer cells: macrophages, T-cellls, natural killer cells, & interleukin 1 & 2
Efficacy:
- Current clinical trials undergoing study
